Search

Your search keyword '"Lee, Jia-Jung"' showing total 215 results
Start Over Author "Lee, Jia-Jung"
215 results on '"Lee, Jia-Jung"'

1. Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial

Author

Lafayette, Richard, Tumlin, James, Fenoglio, Roberta, Kaufeld, Jessica, Pérez Valdivia, Miguel Angel, Wu, Mai-Szu, Susan Huang, Shih-Han, Alamartine, Eric, Kim, Sung Gyun, Yee, Min, Kateifides, Andreas, Rice, Kara, Garlo, Katherine, Barratt, Jonathan, Ranganathan, Dwarakanathan, Wolley, Martin, Tan, Sven-Jean, Chow, Kevin, Tin Law, Mandy Man, Nichols, Kathleen, See, Emily Jan, Steinberg, Adam Glenn, Tiong, Mark, Susan Huang, Shih-Han, Jain, Arsh, Laurin, Louis-Phillipe, Lafrance, Jean-Phillipe, Lamarche, Caroline, Philibert, David, Agharazii, Mohsen, Mac-Way, Fabrice, Alamartine, Eric, Maillard, Nicolas, Mariat, Christophe, Masson, Ingrid, Boffa, Jean-Jacques, Cez, Alexandre, Esteve, Emmanuel, Marchal, Armance, Chauveau, Dominique, Belliere, Julie, Monrozeis, Pauline Bernadet, Colliou, Eloise, Faguer, Stanislas, Huart, Antoine, Ribes, David, Garrouste, Cyril, Heng, Anne-Elisabeth, Mayet, Valentin, Philipponnet, Carole, Moulin, Bruno, Parvez, Laura Braun, Vargas, Gabriela Gautier, Perrin, Peggy, Ohlmann, Sophie, Olagne, Jerome, Haller, Herman, Schmidt-Ott, Kai, Bahlmann-Kroll, Elisabeth, Kaufeld, Jessica, Reinhardt, Martin, Gaeckler, Anja, Dolff, Sebastian, Wilde, Benjamin, Schreiber, Adrian, Koch, Nadine, Seelow, Evelyn, Alberici, Federico, Affatato, Stefania, Mainardi, Allesandro, Mescia, Federica, Scolari, Francesco, Tedesco, Martina, Venturini, Margherita, Cirami, Calogero Lino, Antognoli, Giulia, Caroti, Leonardo, Gualtiero, Gabriele, Moscato, Marcos, Trivioli, Giorgio, La Manna, Gaetano, Baraldi, Olga, Campus, Anita, Stefanini, Carlo, Vischini, Gisella, Roccatello, Dario, Fenoglio, Roberta, Lalloni, Stefania, Sciascia, Savino, Nowicki, Michal, Holub, Tomasz, Kieszek, Błażej, Makówka, Agnieszka, Masajtis, Anna, Piechota, Piotr, Tylski, Maciej, Han, Seung Hyeok, Lee, Sang-Won, Lim, Beon Jin, Pyo, Jung Yoon, Kim, Sung Gyun, An, Jung Nam, Chung, Byung Ha, Kim, Jwa-Kyung, Lee, Hyung Seok, Seo, Young Il, Song, Young Rim, Lee, Hajeong, Park, Sehoon, Han, Seung Seok, Kim, Dong Ki, Kim, Yong Chul, Ryu, Hyunjin, Agraz, Irene, Bolufer, Monica, Hernandez, Josefina Cortés, Gabaldon, Maria Alejandra, Soler, Maria José, Arroyo, David, Carbayo, Javier, Diezhandino, Marian Goicoechea, Perez de Jose, Ana, Guzman, Ursula Verdalles, Moreno, Eduardo Verde, García, Olga Gracia, Albines Fiestas, Zoila Stany, Aladren Gonzalvo, Daniel Joaquin, Gonzalez, Andrea Bernal, Lou Arnal, Luis Miguel, Villarroya, Cristina Medrano, Lopez, Paula Mora, Moncasi, Eduardo Parra, Martin Conde, Maria Luisa, Gonzalez, Jorge, Jatem, Elias, Estor, Aida Moroba, Medrano, Alfons Segarra, Moreno, Antolina Rodriguez, Sanchez de la Nieta, Dolores, Garcia, Clara, Velo, Mercedes, Rocha Castilla, Jose Luis, Bermejo, Sheila, Mendoza, Manuel Lopez, Pérez Valdivia, Miguel Angel, Rojas, Remedios Toledo, Hidalgo, Pilar, Sanchez, Teresa Vazquez, Uriol Rivera, Miguel Giovanni, Fuentes, Mario Lado, Chiu, Yi-Wen, Chang, Jer-Ming, Chen, Hung-Chun, Hsiao, Mei-Ju, Hung, Chi-Chih, Hwang, Shang-Jih, Kuo, Mei Chuan, Kuo, Hung-Tien, Lim, Lee-Moay, Lee, Jia-Jung, Lai, Ping Chin, Chang, David Ray, Chang, Yun-Lun, Chen, I-Ru, Hsieh, Ming-Han, Huang, Chiu-Ching, Kuo, Huey-Liang, Wang, I-Kuan, Wu, Mai-Szu, Chen, Yu-Wei, Chiu, I-Jen, Hsu, Yung-Ho, Hung, Lie-Yee, Laio, Chia-Te, Lin, Gua-Hong, Lin, Yuh-Feng, Wu, Mei-Yi, Zheng, Cai-Mei, Lightstone, Elizabeth, Cairns, Tommy, Mcadoo, Stephen, Medjeral-Thomas, Nicholas, Pickering, Matthew, Robson, Michael, Sinha, Smeeta, Chukwu, Chukwuma, Storrar, Joshua, Ahmed, Sadiq, Cornea, Virgilius, Nadim, Amina, Sims, Tyler, Awad, Ahmed, Aldahan, Mohammed, Clark, Laurie, Lustig, Ryan, Niles, John, Jeyabalan, Anushya, Zonozi, Reza, Tumlin, James, and Paxton, William

Published
2024
Full Text
View/download PDF

2. Gut butyrate-producers confer post-infarction cardiac protection

Author

Chen, Hung-Chih, Liu, Yen-Wen, Chang, Kuan-Cheng, Wu, Yen-Wen, Chen, Yi-Ming, Chao, Yu-Kai, You, Min-Yi, Lundy, David J., Lin, Chen-Ju, Hsieh, Marvin L., Cheng, Yu-Che, Prajnamitra, Ray P., Lin, Po-Ju, Ruan, Shu-Chian, Chen, David Hsin-Kuang, Shih, Edward S. C., Chen, Ke-Wei, Chang, Shih-Sheng, Chang, Cindy M. C., Puntney, Riley, Moy, Amy Wu, Cheng, Yuan-Yuan, Chien, Hsin-Yuan, Lee, Jia-Jung, Wu, Deng-Chyang, Hwang, Ming-Jing, Coonen, Jennifer, Hacker, Timothy A., Yen, C-L. Eric, Rey, Federico E., Kamp, Timothy J., and Hsieh, Patrick C. H.

Published
2023
Full Text
View/download PDF

3. Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidism

Author

Xinling, Liang, Shuangxin, Liu, Sijia, Li, Lixia, Xu, Zhiming, Ye, Zhonglin, Feng, Renwei, Huang, Zhilian, Li, Wei, Chen, Xunhua, Zheng, Naya, Huang, Zhen, Ai, Xin, Wang, former PI, Ni, Zhaohui, present PI, Renhua, Lu, Jianxiao, Shen, Yijun, Zhou, Xinghui, Lin, Yuanyuan, Xie, Jiahui, Zhang, Miaolin, Che, Yan, Fang, Huihua, Pang, Xinyu, Su, Leyi, Gu, Wei, Jin, Peipei, Zhao, Yiwei, Shen, Liou, Zao, Wei, Lu, Haidong, Huang, Gang, Ji, Hao, Li, Deguang, Wang, Liang, Yuan, Lihong, Ding, Xuerong, Wang, Huai, Li, Hong, Liu, Fang, Yuan, Panai, Song, An, Zhou, Xiaojun, Chen, Xiejia, Li, Liyu, He, Xia, Tan, Jing, Chen, Minmin, Zhang, Qian, Zhang, Jing, Qian, Yaozhong, Kong, Youyuan, Chen, Wei, Shen, Guanqing, Xiao, Dezhen, Chen, Dao, Li, Aizhen, Hou, Xiaolei, Li, Hanchang, He, Huizhen, Ye, Zhuxing, Sun, Xiran, Zhang, Weiwei, Shan, Jing, Xue, Yong, Chen, Changying, Xing, Li, Li, Xiangbao, Yu, Kang, Liu, Yifei, Ge, Yili, Xu, Zhimin, Huang, Jingjing, Wu, Bicheng, Liu, Yan, Tu, Mingming, Pan, Hongli, Lin, Dapeng, Wang, Qingyang, Meng, Renna, Luo, Guohua, Ding, Ming, Shi, Changjian, Qiu, Xifeng, Lv, Guojuan, Zhang, Liping, Jiang, Ning, Ding, Huiying, Zhao, Shumin, Bao, Shen, Chen, Qiaojing, Liang, Mei, Zhang, Kanfu, Peng, Pan, Xie, Qian, Yuan, Yan, Zhuo, Shaohua, Li, Yonghui, Mao, Ban, Zhao, Songlan, Wang, Xianguang, Chen, Xiaonong, Chen, Chenni, Gao, Haijin, Yu, Qinjie, Weng, Yuanmeng, Jin, Xiaobo, Ma, Ping, Luo, Dan, Gao, Man, Wu, Yonghui, Qi, Ping, Zhang, Xiaoying, Du, Lihui, Qu, Chunping, Xu, Kaixiang, Sheng, Yi, Yang, Song, Wang, Xinkui, Tian, Hongxia, Guo, Wenhan, Bao, Weifeng, Lin, Sijia, Zhou, Zhuan, Cui, Wenling, Yang, Kaijie, Su, Lian, He, Zhihong, Zhou, Yu, Zheng, Shubei, Zheng, Lingwei, Jin, Yan, Chen, Min, Pan, Wu, Chia-Chao, SungShuei-Liong Lin, Chih-Chien, Wu, Ming-Shiou, Huang, Jenq-Wen, Chiang, Wen Chih, Chiang, Chih-Kang, Yang, Shao-Yu, Wu, Vin-Cent, Huang, Tao-Min, Chen, Yi-Ting, Lai, Tai-Shuan, Lai, Chun-Fu, Tarng, Der-Cherng, Ou, Shuo-Ming, Yang, Chih-Yu, Tseng, Wei-Cheng, Lin, Yao-Ping, Sung, Junne-Ming, Kuo, Te-Hui, Chang, Yu-Tzu, Wu, An-Bang, Lin, Wei-Hung, Fang, Hua-Chang, Chen, Hsin-Yu, Hsu, Chih-Yang, Lee, Po-Tsang, Chen, Chien-Liang, Chou, Kang-Ju, Ho, Tzung-Yu, Lee, Chien-Te, Ng, Hwee-Yeong, Lee, Yueh-Ting, Chiu, Yi-Wen, Kuo, Hung-Tien, Hung, Chi-Chih, Kuo, Mei-Chuan, Lee, Jia-Jung, Tsai, Jer-Chia, Chang, Jer-Ming, Lee-Moay, Lim, Hwang, Shang-Jyh, Hwang, Jyh-Chang, Wang, Hsien-Yi, Kan, Wei-Chih, Wu, Chia-Chun, Jiang, Ming-Yan, Chien, Chih-Chiang, Wu, Ming-Ju, Tsai, Shang-Feng, Chen, Cheng-Hsu, Chen, Hsi-Hsien, Kao, Chih-Chin, Lin, Yen-Chung, Wu, Yueh-Lin, Yeh, Shu-Ching, Mao Chan, Daniel Tak, Yee Mok, Maggie Ming, Yuen Kwan, Lorraine Pui, Wang Chan, Gary Chi, Kim, Yong-Lim, Cho, Jang-Hee, Lim, Jeong-Hoon, Jung, Hee-Yeon, Park, Sun-Hee, Kim, Chan-Duck, Kim, Kyu Yeun, Park, Jung Tak, Yoo, Tae-Hyun, Han, Seung Hyeok, Chung, Wookyung, Jung, Ji Yong, Lee, Hyun Hee, Chang, Jae Hyun, Ro, Han, Kim, Ae Jin, Lee, Jong Soo, Park, Jongha, Park, Kyung Sun, Yoo, Kyoung Don, Chang, Tae Ik, Kang, Ea Wha, Park, Kyoung Sook, Jin, Kyubok, Kim, Yaerim, Paek, Jinhyuk, Park, Wooyeong, Han, Seungyeup, Kwon, Ohyun, Park, Sung Bae, Kim, Myung-gyu, Oh, SeWon, Lee, Jung Pyo, Lee, Jeonghwan, Jung, Jihoon, Park, Cheol Whee, Kim, Hyung Duk, Kim, Sunggyun, Song, Youngrim, Joo, Narae, Lee, Hyungsuk, Choi, Bum-Soon, Park, Hoon Suk, Ban, Tae Hyun, Liang, Xinling, Lu, Kuo-Cheng, Chan, Tak Mao, Fukagawa, Masafumi, Kinoshita, Jun, Nagai, Chisato, Kojima, Masahiro, and Yu, Xueqing

Published
2023
Full Text
View/download PDF

8. Therapy as prevention toward HCV elimination in maintenance hemodialysis: a multi-center, prospective cohort study.

Author

Huang, Chung-Feng, Dai, Chia-Yen, Wang, Chih-Wen, Liang, Po-Cheng, Wei, Yu-Ju, Tsai, Pei-Chien, Jang, Tyng-Yuan, Hsu, Po-Yao, Lee, Jia-Jung, Niu, Sheng-Wen, Huang, Jiun-Chi, Yeh, Ming-Lun, Huang, Ching-I, Hsieh, Ming-Yen, Lin, Yi-Hung, Chen, Szu-Chia, Chiu, Yi-Wen, Huang, Jee-Fu, Chang, Jer-Ming, and Hwang, Shang-Jyh

Subjects
HEPATITIS C virus, PATIENT experience, COHORT analysis, HEMODIALYSIS, LONGITUDINAL method
Abstract

Background The World Health Organization has established interim guidance for hepatitis C virus (HCV) elimination. We aimed to prove the concept of "treatment as prevention" by conducting a prospective HCV elimination program for hemodialysis (HD) patients. Methods A universal HCV screen was launched in 22 HD centers in 2019. HCV-viremic patients were linked to care with direct-acting antivirals (DAAs). The second screen was performed in 2021 to evaluate the effect of link-to-care in lowering the prevalence of HCV viremia and the incidence of HCV new/re-infections. Results Of 2336 patients enrolled in the first screening in 2019, 320 (13.7%) were seropositive for anti-HCV and 181 (7.7%) were HCV-viremic. Of 152 patients successfully linked to treat with DAA, 140 (92.1%) patients achieved a sustained virological response. Of them, 1733 patients participated in the second surveillance. Five anti-HCV-negative patients experienced anti-HCV seroconversion. Of 119 DAA-cured patients and 102 spontaneous HCV clearance patients, none had HCV reinfection. The annual incidence of HCV new infection was 0.1%. Sixty-one of the 620 (9.8%) newly enrolled patients were anti-HCV-seropositive in the second survey. The overall HCV-viremic rate decreased from 7.7% in 2019 to 0.6% (15/2353) in 2021. At the institutional level, 45.5% (10/22) eradicated HCV and 82% (18/22) of HD units had no HCV new infections or reinfections. Conclusions The link-to-care project proved the concept of "treatment as prevention" by which HCV microelimination helps to prevent reinfection and new infections in the HD population. Trial registration: ClinicalTrials.gov identifier: NCT03803410 and NCT03891550. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

9. Signal Quality Analysis of Single-Arm Electrocardiography

Author

Lee, Jia-Jung Wang, Shing-Hong Liu, Cheng-Hsien Tsai, Ioannis Manousakas, Xin Zhu, and Thung-Lip

Subjects
electrocardiogram (ECG), single-arm ECG, R-to-R wave interval (RRI), heart rate variability (HRV), signal-to-noise ratio (SNR)
Abstract

The number of people experiencing mental stress or emotional dysfunction has increased since the onset of the COVID-19 pandemic, as many individuals have had to adapt their daily lives. Numerous studies have demonstrated that mental health disorders can pose a risk for certain diseases, and they are also closely associated with the problem of mental workload. Now, wearable devices and mobile health applications are being utilized to monitor and assess individuals’ mental health conditions on a daily basis using heart rate variability (HRV), typically measured by the R-to-R wave interval (RRI) of an electrocardiogram (ECG). However, portable or wearable ECG devices generally require two electrodes to perform bipolar limb leads, such as the Einthoven triangle. This study aims to develop a single-arm ECG measurement method, with lead I ECG serving as the gold standard. We conducted static and dynamic experiments to analyze the morphological performance and signal-to-noise ratio (SNR) of the single-arm ECG. Three morphological features were defined, RRI, the duration of the QRS complex wave, and the amplitude of the R wave. Thirty subjects participated in this study. The results indicated that RRI exhibited the highest cross-correlation (R = 0.9942) between the single-arm ECG and lead I ECG, while the duration of the QRS complex wave showed the weakest cross-correlation (R = 0.2201). The best SNR obtained was 26.1 ± 5.9 dB during the resting experiment, whereas the worst SNR was 12.5 ± 5.1 dB during the raising and lowering of the arm along the z-axis. This single-arm ECG measurement method offers easier operation compared to traditional ECG measurement techniques, making it applicable for HRV measurement and the detection of an irregular RRI.

Published
2023
Full Text
View/download PDF

11. Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan : national prospective cohort study

Author

Taiwan Allopurinol-SCAR Consortium, Ko, Tai-Ming, Tsai, Chang-Youh, Chen, Shih-Yang, Chen, Kuo-Shu, Yu, Kuang-Hui, Chu, Chih-Sheng, Huang, Chung-Ming, Wang, Chrong-Reen, Weng, Chia-Tse, Yu, Chia-Li, Hsieh, Song-Chou, Tsai, Jer-Chia, Lai, Wen-Ter, Tsai, Wen-Chan, Yin, Guang-Dar, Ou, Tsan-Teng, Cheng, Kai-Hung, Yen, Jeng-Hsien, Liou, Teh-Ling, Lin, Tsung-Hsien, Chen, Der-Yuan, Hsiao, Pi-Jung, Weng, Meng-Yu, Chen, Yi-Ming, Chen, Chen-Hung, Liu, Ming-Fei, Yen, Hsueh-Wei, Lee, Jia-Jung, Kuo, Mei-Chuan, Wu, Chen-Ching, Hung, Shih-Yuan, Luo, Shue-Fen, Yang, Ya-Hui, Chuang, Hui-Ping, Chou, Yi-Chun, Liao, Hung-Ting, Wang, Chia-Wen, Huang, Chun-Lin, Chang, Chia-Shuo, Lee, Ming-Ta Michael, Chen, Pei, Wong, Chih-Shung, Chen, Chien-Hsiun, Wu, Jer-Yuarn, Chen, Yuan-Tsong, and Shen, Chen-Yang

Published
2015

18. Review of the present features and the infection control challenges of <scp>COVID</scp> ‐19 pandemic in dialysis facilities

Author

Lee, Jia‐Jung, Hwang, Shang‐Jyh, and Huang, Jee‐Fu

Subjects
Pneumonia, Viral, Population, Taiwan, Review Article, Comorbidity, Ambulatory Care Facilities, Betacoronavirus, COVID‐19, Renal Dialysis, Interim, Pandemic, Humans, Medicine, Infection control, Renal Insufficiency, education, Review Articles, Health Education, Pandemics, Personal Protective Equipment, lcsh:R5-920, Infection Control, education.field_of_study, hemodialysis, SARS-CoV-2, business.industry, COVID-19, General Medicine, medicine.disease, Triage, Preparedness, Health education, Medical emergency, lcsh:Medicine (General), Coronavirus Infections, business, Dialysis (biochemistry)
Abstract

The COVID‐19 has swept the world causing suffering, death, loss, and massive economy damage. The dialysis population is vulnerable and the dialysis facility is critical in maintaining operations and avoiding disease transmission. The present information regarding the clinical features of COVID‐19 infection in the dialysis population was collected, and the useful measures of COVID‐19 infection prevention and infection control in the dialysis facilities were summarized. Leadership, education, preparedness, management, and recovery phase were determined to be the critical procedures. It is hoped this updated interim review might provide information for medical professionals to take proactive action to best prepare and mitigate damage when facing the COVID‐19 pandemic challenge.

Published
2020
Full Text
View/download PDF

22. Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study

Author

Ko, Tai-Ming, Tsai, Chang-Youh, Chen, Shih-Yang, Chen, Kuo-Shu, Yu, Kuang-Hui, Chu, Chih-Sheng, Huang, Chung-Ming, Wang, Chrong-Reen, Weng, Chia-Tse, Yu, Chia-Li, Hsieh, Song-Chou, Tsai, Jer-Chia, Lai, Wen-Ter, Tsai, Wen-Chan, Yin, Guang-Dar, Ou, Tsan-Teng, Cheng, Kai-Hung, Yen, Jeng-Hsien, Liou, Teh-Ling, Lin, Tsung-Hsien, Chen, Der-Yuan, Hsiao, Pi-Jung, Weng, Meng-Yu, Chen, Yi-Ming, Chen, Chen-Hung, Liu, Ming-Fei, Yen, Hsueh-Wei, Lee, Jia-Jung, Kuo, Mei-Chuan, Wu, Chen-Ching, Hung, Shih-Yuan, Luo, Shue-Fen, Yang, Ya-Hui, Chuang, Hui-Ping, Chou, Yi-Chun, Liao, Hung-Ting, Wang, Chia-Wen, Huang, Chun-Lin, Chang, Chia-Shuo, Lee, Ming-Ta Michael, Chen, Pei, Wong, Chih-Shung, Chen, Chien-Hsiun, Wu, Jer-Yuarn, Chen, Yuan-Tsong, and Shen, Chen-Yang

Published
2015
Full Text
View/download PDF

24. The association between hepatitis C virus infection and renal function

Author

Gantumur, Gantsetseg, primary, Batsaikhan, Batbold, additional, Huang, Ching-I, additional, Yeh, Ming-Lun, additional, Huang, Chung-Feng, additional, Lin, Yi-Hung, additional, Lin, Tzu-Chun, additional, Liang, Po-Cheng, additional, Liu, Ta-Wei, additional, Lee, Jia-Jung, additional, Lin, Yi-Ching, additional, Lin, I-Ling, additional, Huang, Jee-Fu, additional, Chuang, Wan-Long, additional, Yu, Ming-Lung, additional, Tu, Hung-Pin, additional, and Dai, Chia-Yen, additional

Published
2021
Full Text
View/download PDF

25. Comorbidities in patients with chronic hepatitis C and hepatitis B on hemodialysis

Author

Hsu, Po‐Yao, primary, Wei, Yu‐Ju, additional, Liang, Po‐Cheng, additional, Lee, Jia‐Jung, additional, Niu, Sheng‐Wen, additional, Huang, Jiun‐Chi, additional, Hsu, Cheng‐Ting, additional, Jang, Tyng‐Yuan, additional, Huang, Ching‐I, additional, Lin, Yi‐Hung, additional, Hsieh, Ming‐Yen, additional, Hsieh, Meng‐Hsuan, additional, Chen, Szu‐Chia, additional, Dai, Chia‐Yen, additional, Lin, Zu‐Yau, additional, Chen, Shinn‐Cherng, additional, Huang, Jee‐Fu, additional, Chang, Jer‐Ming, additional, Yeh, Ming‐Lun, additional, Huang, Chung‐Feng, additional, Chiu, Yi‐Wen, additional, Hwang, Shang‐Jyh, additional, Chuang, Wan‐Long, additional, and Yu, Ming‐Lung, additional

Published
2021
Full Text
View/download PDF

27. Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan—the Formosa‐Like Group

Author

Wei, Yu‐Ju, primary, Hsu, Po‐Yao, additional, Lee, Jia‐Jung, additional, Niu, Sheng‐Wen, additional, Huang, Jiun‐Chi, additional, Hsu, Cheng‐Ting, additional, Jang, Tyng‐Yuan, additional, Yeh, Ming‐Lun, additional, Huang, Ching‐I, additional, Liang, Po‐Cheng, additional, Lin, Yi‐Hung, additional, Hsieh, Ming‐Yen, additional, Hsieh, Meng‐Hsuan, additional, Chen, Szu‐Chia, additional, Dai, Chia‐Yen, additional, Lin, Zu‐Yau, additional, Chen, Shinn‐Cherng, additional, Huang, Jee‐Fu, additional, Chang, Jer‐Ming, additional, Hwang, Shang‐Jyh, additional, Chuang, Wan‐Long, additional, Huang, Chung‐Feng, additional, Chiu, Yi‐Wen, additional, and Yu, Ming‐Lung, additional

Published
2021
Full Text
View/download PDF

28. Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis

Author

Hsu, Po-Yao, primary, Wei, Yu-Ju, additional, Lee, Jia-Jung, additional, Niu, Sheng-Wen, additional, Huang, Jiun-Chi, additional, Hsu, Cheng-Ting, additional, Jang, Tyng-Yuan, additional, Yeh, Ming-Lun, additional, Huang, Ching-I, additional, Liang, Po-Cheng, additional, Lin, Yi-Hung, additional, Hsieh, Ming-Yen, additional, Hsieh, Meng-Hsuan, additional, Chen, Szu-Chia, additional, Dai, Chia-Yen, additional, Lin, Zu-Yau, additional, Chen, Shinn-Cherng, additional, Huang, Jee-Fu, additional, Chang, Jer-Ming, additional, Hwang, Shang-Jyh, additional, Chuang, Wan-Long, additional, Huang, Chung-Feng, additional, Chiu, Yi-Wen, additional, and Yu, Ming-Lung, additional

Published
2021
Full Text
View/download PDF

29. Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C)

Author

Yu, Ming-Lung, primary, Huang, Chung-Feng, additional, Wei, Yu-Ju, additional, Lin, Wen-Yi, additional, Lin, Yi-Hung, additional, Hsu, Po-Yao, additional, Hsu, Cheng-Ting, additional, Liu, Ta Wei, additional, Lee, Jia-Jung, additional, Niu, Sheng-Wen, additional, Huang, Jiun-Chi, additional, Hung, Tzu-Sui, additional, Yeh, Ming-Lun, additional, Huang, Ching-I, additional, Liang, Po-Cheng, additional, Hsieh, Ming-Yen, additional, Chen, Szu-Chia, additional, Huang, Jee-Fu, additional, Chang, Jer-Ming, additional, Chiu, Yi-Wen, additional, Dai, Chia-Yen, additional, Hwang, Shang-Jyh, additional, and Chuang, Wan-Long, additional

Published
2020
Full Text
View/download PDF

31. The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C

Author

Lee, Jia-Jung, primary, Wei, Yu-Ju, additional, Lin, Ming-Yen, additional, Niu, Sheng-Wen, additional, Hsu, Po-Yao, additional, Huang, Jiun-Chi, additional, Jang, Tyng-Yuan, additional, Yeh, Ming-Lun, additional, Huang, Ching-I, additional, Liang, Po-Cheng, additional, Lin, Yi-Hung, additional, Hsieh, Ming-Yen, additional, Hsieh, Meng-Hsuan, additional, Chen, Szu-Chia, additional, Dai, Chia-Yen, additional, Lin, Zu-Yau, additional, Chen, Shinn-Cherng, additional, Huang, Jee-Fu, additional, Chang, Jer-Ming, additional, Hwang, Shang-Jyh, additional, Huang, Chung-Feng, additional, Chiu, Yi-Wen, additional, Chuang, Wan-Long, additional, and Yu, Ming-Lung, additional

Published
2020
Full Text
View/download PDF

32. Epidemiological evolution of viral hepatitis in uremic patients in Taiwan - the Formosa like group

Author

Wei, Yu-Ju, primary, Lee, Jia-Jung, additional, Huang, Chung-Feng, additional, Huang, Ching-I, additional, Yeh, Ming-Lun, additional, Chen, Szu-Chia, additional, Niu, Sheng-Wen, additional, Yang, Lii-Jia, additional, Dai, Chia-Yen, additional, Huang, Jee-Fu, additional, Hwang, Shang-Jyh, additional, Chuang, Wan-Long, additional, Chiu, Yi Wen, additional, and Yu, Ming-Lung, additional

Published
2020
Full Text
View/download PDF

38. Ratio of Early Mitral Inflow Velocity to the Global Diastolic Strain Rate and Global Left Ventricular Longitudinal Systolic Strain Predict Overall Mortality and Major Adverse Cardiovascular Events in Hemodialysis Patients

Author

Huang, Jiun-Chi, primary, Su, Ho-Ming, additional, Wu, Pei-Yu, additional, Lee, Jia-Jung, additional, Lee, Wen-Hsien, additional, Chen, Szu-Chia, additional, Chiu, Yi-Wen, additional, Hsu, Ya-Ling, additional, Chang, Jer-Ming, additional, and Chen, Hung-Chun, additional

Published
2019
Full Text
View/download PDF

41. Independent Association of Overhydration with All-Cause and Cardiovascular Mortality Adjusted for Global Left Ventricular Longitudinal Systolic Strain and E/E’ Ratio in Maintenance Hemodialysis Patients

Author

Huang, Jiun-Chi, primary, Tsai, Yi-Chun, additional, Wu, Pei-Yu, additional, Lee, Jia-Jung, additional, Chen, Szu-Chia, additional, Chiu, Yi-Wen, additional, Hsu, Ya-Ling, additional, Chang, Jer-Ming, additional, and Chen, Hung-Chun, additional

Published
2018
Full Text
View/download PDF

44. Generation of an induced pluripotent stem cell line, IBMS-iPSC-014-05, from a female autosomal dominant polycystic kidney disease patient carrying a common mutation of R803X in PKD2

Author

Ho, Ming-Ching, primary, Huang, Ching-Ying, additional, Lee, Jia-Jung, additional, Hsu, Shih-Han, additional, Cheng, Yu-Che, additional, Hsu, Yu-Hung, additional, Hwang, Daw-Yang, additional, Lu, Huai-En, additional, Chen, Hung-Chun, additional, and Hsieh, Patrick C.H., additional

Published
2017
Full Text
View/download PDF

45. Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C)

Author

Yu, Ming-Lung, Huang, Chung-Feng, Wei, Yu-Ju, Lin, Wen-Yi, Lin, Yi-Hung, Hsu, Po-Yao, Hsu, Cheng-Ting, Liu, Ta Wei, Lee, Jia-Jung, Niu, Sheng-Wen, Huang, Jiun-Chi, Hung, Tzu-Sui, Yeh, Ming-Lun, Huang, Ching-I, Liang, Po-Cheng, Hsieh, Ming-Yen, Chen, Szu-Chia, Huang, Jee-Fu, Chang, Jer-Ming, Chiu, Yi-Wen, Dai, Chia-Yen, Hwang, Shang-Jyh, and Chuang, Wan-Long

Abstract

ObjectiveHCV prevails in uremic haemodialysis patients. The current study aimed to achieve HCV microelimination in haemodialysis centres through a comprehensive outreach programme.DesignThe ERASE-C Campaign is an outreach programme for the screening, diagnosis and group treatment of HCV encompassing 2323 uremic patients and 353 medical staff members from 18 haemodialysis centres. HCV-viremic subjects were linked to care for directly acting antiviral therapy or received on-site sofosbuvir/velpatasvir therapy. The objectives were HCV microelimination (>80% reduction of the HCV-viremic rate 24 weeks after the end of the campaign in centres with ≥90% of the HCV-viremic patients treated) and ‘No-C HD’ (no HCV-viremic subjects at the end of follow-up).ResultsAt the preinterventional screening, 178 (7.7%) uremic patients and 2 (0.6%) staff members were HCV-viremic. Among them, 146 (83.9%) uremic patients received anti-HCV therapy (41 link-to-care; 105 on-site sofosbuvir/velpatasvir). The rates of sustained virological response (SVR12, undetectable HCV RNA 12 weeks after the end of treatment) in the full analysis set and per-protocol population were 89.5% (94/105) and 100% (86/86), respectively, in the on-site treatment group, which were comparable with the rates of 92.7% (38/41) and 100% (38/38), respectively, in the link-to-care group. Eventually, the HCV-viremic rate decreased to 0.9% (18/1,953), yielding an 88.3% reduction from baseline. HCV microelimination and ‘No-C HD’ were achieved in 92.3% (12/13) and 38.9% (7/18) of the haemodialysis centres, respectively.ConclusionOutreach strategies with mass screenings and on-site group treatment greatly facilitated HCV microelimination in the haemodialysis population.ClinicalTrials.gov identifierNCT03803410and NCT03891550

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results